Prescribing information



Welcome to the British Society for Haematology event page. Below you can access recordings from the Novartis-sponsored sessions which took place at the BSH Annual Scientific meeting on 3rd–5th April 2022. All the individual presentations from the Novartis-sponsored symposiums are available for you to watch, at a time that is convenient for you.


Video thumbnail placeholder

The Clinical Application of Next-Generation Sequencing in Myelofibrosis

In this symposium, Dr Rebecca Frewin, Consultant Haematologist at the Gloucestershire Hospitals NHS Trust, and Dr Donal McLornan, Consultant Haematologist at the Guy’s and St Thomas’/University College London Hospitals discuss clinical application of next-generation sequencing in myelofibrosis (NGS).

Access symposium recordings


Video thumbnail placeholder

A heritage in ITP: Improving the symptoms that matter to patients

In this symposium, Dr Nichola Cooper, Consultant Haematologist at Imperial College Healthcare NHS Trust, London, Prof. Mark Gurnell, Consultant Endocrinologist at University of Cambridge, School of Medicine and Dr Quentin Hill, Consultant Haematologist and Honorary Clinical Associate Professor at Leeds Teaching Hospitals discuss how to improve the symptoms that matter to patients with immune thrombocytopenia (ITP).

Access symposium recordings


Video thumbnail placeholder

The importance of coordinating patient care and the practicalities of running an infusion centre for
Adakveo® (crizanlizumab)

In this presentation, Dr Martin Besser, Consultant Haematologist at Cambridge University NHS Foundation Trust and Dr Joe Sharif, Consultant Haematologist, Manchester University NHS Foundation Trust, discuss their experience of managing coordinated care for patients with haemoglobinopathies and explore the use of crizanlizumab in the management of sickle cell disease.

Access symposium slides

Rate this content: 
No votes yet
UK | April 2022 | 204547

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at